GUMDROP : JHMI J0915 Phase I, First in Human Study of Orally Administered AMG 900 in Adult Subjects with Advanced Solid Tumors

Description:

Advanced solid tumors w/ tumor tissue that is accessible for biopsy by fine needle aspiration; NO active parenchymal brain mets, NO active or chronic hepatitis B or C

Link:

http://clinicaltrials.gov/ct2/show/NCT00858377

 

Site:

Johns Hopkins Hospital

Principal Investigator:

Michael Carducci, M.D.